Internal Medicine, Infectious Disease · Flemington, NJ
NPI
1619949575
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
121 State Route 31 Ste 300
Flemington, NJ, 08822
Phone (908) 788-6474
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
632 services
Medicare patients, 2024
173
Average age 73
Drug cost, 2024
$876K
1,207 prescriptions
Company payments, 2025
$190
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph L Gugliotta was code 99214 (office e&m - established), 317 times for 144 patients. In total Joseph L Gugliotta billed 632 services in 21 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 317 | 144 | $103.51 | $33K |
| 99215 Office E&M - Established | Office | 82 | 60 | $135.04 | $11K |
| 99205 Office E&M - New | Office | 76 | 76 | $179.58 | $14K |
| 99213 Office E&M - Established | Office | 47 | 34 | $70.82 | $3,329 |
By year: 2022 $42K for 443 services; 2023 $53K for 492 services; 2024 $66K for 632 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph L Gugliotta prescribed most often to Medicare patients was Methenamine Hippurate, with 74 prescriptions and refills. In total Joseph L Gugliotta wrote 1,207 Medicare prescriptions that cost $876K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methenamine Hippurate Generic | 74 | 108 | Under 11 | $6,124 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 57 | 65 | Under 11 | $252K |
| Allopurinol Generic | 47 | 79 | Under 11 | $297 |
| Tivicay Dolutegravir Sodium | 41 | 41 | Under 11 | $96K |
| Juluca Dolutegravir/Rilpivirine | 40 | 40 | Under 11 | $145K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 39 | 39 | Under 11 | $152K |
| Cephalexin Generic | 39 | 43 | 11 | $488 |
| Amoxicillin Generic | 38 | 74 | 12 | $1,014 |
| Gabapentin Generic | 32 | 32 | Under 11 | $174 |
| Prednisone Generic | 28 | 44 | Under 11 | $206 |
| Azithromycin Generic | 27 | 27 | Under 11 | $354 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 25 | 35 | Under 11 | $4,607 |
| Hydrochlorothiazide Generic | 23 | 25 | Under 11 | $33.78 |
| Ethambutol Hcl Generic | 22 | 22 | Under 11 | $716 |
| Isentress Raltegravir Potassium | 20 | 20 | Under 11 | $40K |
Brand drugs: 301 claims; generic drugs: 906 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph L Gugliotta $190 ($190 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $53.28.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.